MARKET NEWS

Microfluidics Enables Reliable siRNA Drug Delivery for Inflammatory Diseases & Tumor Targeting
Ajinomoto Bio-Pharma Services Signs Manufacturing Agreement With Humanigen for Lenzilumab, Currently in FDA-Approved Phase 3 Study for COVID-19
KBP Biosciences Completes Enrollment of BLOCK CKD Phase 2b Study
Alethia Biotherapeutics Announces Receipt of FDA Authorization to Begin Phase 2 Development
Catalent Announces Acquisition of Japanese Facility to Provide Local & Global Clinical Supply Solutions
eGenesis Strengthens Production Capabilities With Acquisition of ICBiotec
Vaxart Announces Selection of its Oral COVID-19 Vaccine Lead Candidate

  FEATURED EDITORIAL

  COMPANY PROFILE


The Health business of Lubrizol Life Science (LLS Health) partners with customers to speed innovative differentiated pharmaceutical products and medical devices to market. Our team provides multifunctional polymers and excipients, as well as product design, development, and manufacturing services. LLS Health offers high-quality development and production of added value nutraceutical ingredients, providing nutritional and technical solutions for clients’ final products brands in the functional foods and dietary supplements industries. Click here for more.

Headquartered in Nashville,TN PMI BioPharma Solutions is a team of highly experienced life science experts providing rigorous research, pharmaceutical development, and clinical manufacturing services to clients in the pharmaceutical and biotechnology space. We pride ourselves on our abilities, integrity, and persistence in the face of challenge, and will exert maximal effort and ingenuity to achieve your goals. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Wondering if Investing in a Higher Purity Excipient is Really Going to Pay Off?

Wondering if Investing in a Higher Purity Excipient is Really Going to Pay Off?

Wondering if investing in a higher purity excipient is really going to pay off? Check out our video web series where we speak to 3 subject matter experts on the benefits of…..

WEBINAR ALERT- From Diluent to Differentiator: How to Choose a Diluent System That Differentiates Your Lyophilized Product

WEBINAR ALERT- From Diluent to Differentiator: How to Choose a Diluent System That Differentiates Your Lyophilized Product

Along with a rapidly expanding global market for innovative lyophilized biologics come increased cost and competitive pressures. Today, it is critical that….

Apollomics Announces Initiation of SPARTA Phase 2 Clinical Trial

Apollomics Announces Initiation of SPARTA Phase 2 Clinical Trial

Apollomics, Inc. recent announced the initiation of the Phase 2 portion of the Phase 1/2 clinical trial for APL-101 based on completion of the Phase 1 and approval from the….

FDA Approves Octapharma USA Investigational New Drug Application for Severe COVID-19 Patients

FDA Approves Octapharma USA Investigational New Drug Application for Severe COVID-19 Patients

The US FDA has recently approved the investigational new drug (IND) application submitted by Octapharma USA for a Phase 3 clinical trial on…

SeraNovo Enters Second License Agreement With Carna Biosciences

SeraNovo Enters Second License Agreement With Carna Biosciences

SeraNovo B.V. recently announced it has signed a second License Agreement with Carna Biosciences, Inc., a company engaged in the drug development of….